with idiopathic complete isolated GHD (peak GH on provocative stimuli below 4 ng/ml, otherwise normal pituitary function), group 2 3 pts (2m, If, age 6-14yrs, height -1.8 to 2.2 SD) with idiopathic partial isolated GHD (peak GH above 4 and below 7 ng/ml), group 3 2 girls (age 2 and 17 yrs, height -2.0 and -3.1 SD) with idiopathic panhypopituitarism, and group 4 8 pts (6m, 2f, age 7-12yrs, height -2.6 ?I 0.9 SD) with acquired hypopituitarism: 4 with isolated hypopituitarism (3 post-radiation, 1 craniopharyngioma), 4 with panhypopituitarism (2 craniopharyngioma, 1 glioma, 1 histiocytosis X). Density in the intrasellar area on mcorresponded to that of cerebrospinal fluid in 12 of 18 pts (group l), 0/3 (group 2), 1/2 (group 3), and 2/8 (group 4, both postradiation). The overall incidence of PESS in the GID pts studied was thus over 48% bile in children without endocrine dysfunction, it was only 5/213. It is concluded that PESS is more frequent than was assumed until now and that is most frequently associated with GHD. c.pellin;.~.di Natale", ~.~et=ca", ~.~boldi*, ~.%iulzi*,
Pediah-ics, Endocrine Unit,Dept. of Nanoradiology.University of Milan, Italy.
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To search for the presence of morplrstrucb-al atoonmlities of the hypthalans years) because of declining height velocity. Arginine and insulin failed to induce GH release whereas TRH test results and cortisol response to insulin were normal. Skull radiographies did not show any abnormalities. On CT scan the pituitary stalk was suspected to be abnormal, but only with magnetic resonance imaging (MRI) a small round posterior nodule of the pituitary stalk was clearly demonstrated in both cases. Its qualitative appearance was equal to neurohypophyseal tissue. The lower part of the stalk was reduced to a filament leading to a hypoplastic pituitary gland which seemed to lack the posterior lobe. This suggests that in our patients the neurohypophysis may be located in an ectopic position attached to the pituitary stalk. Biopsy or surgical removal was avoided. The patients responded markedly to hGH therapy. At present, a malformation of the pituitary stalk seems to be a rare cause of GH insufficiency, but it is likely that a more extensive use of MRI for evaluation of apparent idiopathic hypopituitarism may reveal a higher incidence of such anomalies. TRANSIENT GROWTH HORMONE DEFICIENCY DURING BROMOCRYP-TINE TREATMENT FOR HYPERPROLACTINEMIA Growth hormone (GH) deficiency has been demonstrated in several patients with prolactinoma. Very often it was attrituted to tumor expansion and found to be permanent after surgery. In a 14-year-old boy with galactorrhea, arrested puberty (testesvolume 4ml) and poor growth (3cmIyear) elevated prolactin (PRL) levels (5800 mull) were found. MR imaging showed no abnormalities of the pituary gland. Nighttime sampling revealed persistent PRL elevation and low GH peaks (max. 12 mull). GH response to insuline induced hypoglycemia was also low (max. 10 mUI11 but GH increased normally after GRF injection (38 mull). Basal and stimulated LH and FSH values were prepubertal. 3 h. after the administration of 10 mg bromocryptine (B) PRL dropped to normal values and GH increased to 22 mU11. After six months of treatment with B, height velocity doubled and normalization of GH secretion was observed. Basal LH, FSH and testosterone values remained prepubertal. In conclusion, GH deficiency in hyperprolaetinemia can be restored during B treatment. The acute GH response to B may be predictive of the subsequent normalization of GH secretion during long term treatment. In isolated hyperprolaetinemia a central dopaminergie defect is probably responsible for this deficient GH secretion. One hundred Iorty nine children and adolescents with growth hormone (hGII) deficiency were reviewed retrospcctivcly in rclation to plasma basal and TKll stimulated prolactin (Prl) Levels before and during long-term hCll therapy. The Collowing groups werc distinguished: Cr. 1 -TCHD (n.62, 41M, 21F); Cr. 11 -MPIID (n=62, 44M, 18F); Gr. 111 -Intra-or suprasellsr tumors (11.25, 17M, 8F). lligh basal Prl ( 7 20 ngldl) were found in 6 ICIID patients (9.7%). During hcll therapy Prl normalized in all six. Nineteen (30.7%) MPllD pnticnts had high basal Prl. Following L-T4 therapy Prl normalized in 14 of them. All MPllD patients with high basal Prl had higher than normal TSll response to TRH. High basal Prl levels wert unrclatcd to stress and E2 thcrnpy. It is assumed that in some hypopituitary patients hCll deficiency is due to hyponctivity of thc cntccholaminergic tone lcading to GII-RH deficicncy and high Prl Icvcls. This is reversed by hCll therapy. A low response of Pr was found in 10 IGllD and 10 (16.1%) MPllD paticnts. A pituitary lesion was proven in these patients by a low response of CH to CII-RII and TSH to TRH. It thus secms that some TCIID patients arL actually MPllD being deficient in both hCH and Prl. In the tumor patients, 2 had high Prl preoparatively. Post-op 5 had a low Prl rcsponsc to TRH indicating complete~hypophyscctomy and 6 develope high Prl levels indicating hypothalamic or stalk injury. It is concluded that dynamics of hPrl secretion should be investigated in all hypopituitary patients, including ICIID.
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